THERAPEUTIC AREAS
Gastro Enterology
The prevalence of chronic constipation has been reported to range between 5% and 15% of the general population, depending on the size and type of assessment, the definition of constipation, and variables such as nationality, culture, and the healthcare system.
Specializing in designing innovative drugs for constipated patients, SALSARULO Pharma has always taken patient comfort in priority as well as business challenges that pharmaceutical companies are facing in their respective markets.
Others
SALSARULO Pharma is also investing in the branches of analgesics and the cardiology medical market.